Welcome to LookChem.com Sign In|Join Free

CAS

  • or

71952-92-6

Post Buying Request

71952-92-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

71952-92-6 Usage

Description

(4Z,6E,10E)-19-[(2-chloroethyl)amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate is a complex organic compound characterized by its intricate chemical structure. It features a carbamate group, a chloroethylamino group, multiple hydroxy and methoxy functional groups, a bicyclic structure with several double bonds, and a variety of methyl groups. (4Z,6E,10E)-19-[(2-chloroethyl)amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate may hold potential applications in the pharmaceutical or agricultural industries due to its unique structural and functional attributes, although further research is required to ascertain its full potential and properties.

Uses

Used in Pharmaceutical Industry:
(4Z,6E,10E)-19-[(2-chloroethyl)amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate is used as a potential pharmaceutical agent for [application reason], leveraging its unique chemical structure and functional groups to target specific biological processes or interact with certain receptors.
Used in Agricultural Industry:
In the agricultural sector, (4Z,6E,10E)-19-[(2-chloroethyl)amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate is used as a [application type] for [application reason], potentially offering novel solutions to challenges in crop protection, pest control, or other agricultural applications.

Check Digit Verification of cas no

The CAS Registry Mumber 71952-92-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,9,5 and 2 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 71952-92:
(7*7)+(6*1)+(5*9)+(4*5)+(3*2)+(2*9)+(1*2)=146
146 % 10 = 6
So 71952-92-6 is a valid CAS Registry Number.

71952-92-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Geldanamycin, 17-[(2-chloroethyl)amino]-17-demethoxy-

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:71952-92-6 SDS

71952-92-6Downstream Products

71952-92-6Relevant articles and documents

GELDANAMYCIN AND DERIVATIVES INHIBIT CANCER INVASION AND IDENTIFY NOVEL TARGETS

-

Page/Page column 44; 45, (2008/06/13)

Geldanamycin derivatives that block the uPA-plasmin network and inhibit growth and invasion by glioblastoma cells and other tumors at femtomolar concentrations are potentially highly active anti-cancer drugs. GA and various 17-amino-17-demethoxygelddanamycin derivatives are disclosed that block HGF/SF-mediated Met tyrosine kinase receptor-dependent uPA activation at fM levels. Other ansamycins (macbecins I and II), GA derivatives, and radicicol required concentrations several logs higher (≥nM) to achieve such inhibition. The inhibitory activity of tested compounds was discordant with the known ability of drugs of this class to bind to hsp90, indicating the existence of a novel target(s) for HGF/SF -mediated events in tumor development. Methods of using such compounds to inhibit cancer cell activities and to treat tumors are disclosed. Such treatment with low doses of these highly active compounds provide an option for treating various Met-expressing tumors, in particular invasive brain cancers, either alone or in combination with conventional surgery, chemotherapy, or radiotherapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 71952-92-6